Cortisone acetate
- Generic Name
- Cortisone acetate
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C23H30O6
- CAS Number
- 50-04-4
- Unique Ingredient Identifier
- 883WKN7W8X
- Background
Cortisone acetate was first isolate in 1935 and became more widely researched in 1949. Since then, glucocorticoids such as cortisone acetate have been used to treat a number of inflammatory conditions such as endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, respiratory, hematologic, neoplastic, edematous, and gastrointestinal diseases and disorders.
Cortisone acetate was granted FDA approval on 13 June 1950.
- Indication
Cortisone acetate is indicated to treat a wide variety of endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, respiratory, hematologic, neoplastic, edematous, and gastrointestinal diseases and disorders.
- Associated Conditions
- Acute Gouty Arthritis, Acute Leukemia, Adrenocortical Hyperfunction, Adrenocortical Insufficiency, Allergic Conjunctivitis (AC), Ankylosing Spondylitis (AS), Aspiration Pneumonitis, Asthma, Atopic Dermatitis, Berylliosis, Bullous dermatitis herpetiformis, Bursitis, Chorioretinitis, Choroiditis, Congenital Adrenal Hyperplasia (CAH), Congenital Hypoplastic Anemia, Contact Dermatitis, Cushing's Syndrome, Drug hypersensitivity reaction, Epicondylitis, Erythroblastopenia, Hypercalcemia of Malignancy, Immune Thrombocytopenia (ITP), Inflammation, Iridocyclitis, Iritis, Keratitis, Loeffler's syndrome, Lymphoma, Meningitis caused by Mycobacterium Tuberculosis, Mycosis Fungoides (MF), Ophthalmia, Sympathetic, Optic Neuritis, Pemphigus, Perennial Allergic Rhinitis (PAR), Posttraumatic Osteoarthritis, Psoriatic Arthritis, Regional Enteritis, Rheumatoid Arthritis, Rheumatoid Arthritis, Juvenile, Rosacea, Seasonal Allergic Rhinitis, Secondary thrombocytopenia, Serum Sickness, Severe Seborrheic Dermatitis, Stevens-Johnson Syndrome, Synovitis, Systemic Lupus Erythematosus, Tenosynovitis, Trichinosis, Tuberculosis (TB), Ulcerative Colitis, Uveitis, Acquired immune hemolytic anemia, Acute rheumatic carditis, Anterior eye segment inflammation, Exfoliative erythroderma, Non-suppurative Thyroiditis, Severe Psoriasis, Symptomatic Sarcoidosis, Varicella-zoster virus acute retinal necrosis
- Associated Therapies
- -
Randomized, Double-blind, Two Arms, Multicenter, Phase III Study of Berinert for Treatment of ACE Induced Angioedema
- Conditions
- Interventions
- First Posted Date
- 2013-04-30
- Last Posted Date
- 2023-11-24
- Lead Sponsor
- Technical University of Munich
- Target Recruit Count
- 31
- Registration Number
- NCT01843530
- Locations
- 🇩🇪
Kath. Klinikum Bochum, Med. Klinik III, Bochum, Germany
🇩🇪Ludwig-Maximilian-Universität, München, Germany
🇩🇪Klinikum rechts der Isar, Hals-Nasen-Ohren Klinik, München, Germany
Continuous Subcutaneous Hydrocortisone Infusion in Congenital Adrenal Hyperplasia
- Conditions
- Interventions
- First Posted Date
- 2013-01-18
- Last Posted Date
- 2016-12-21
- Lead Sponsor
- Haukeland University Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT01771328
- Locations
- 🇳🇴
Haukeland Universitetssykehus, Department of Medicine, Bergen, Norway
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.